Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
Abstract Vascular endothelial growth factor tyrosine kinase inhibitors (VEGF-TKIs) have been the mainstay of treatment for patients with advanced renal cell carcinoma (RCC). Despite its early promising results in decreasing or delaying the progression of RCC in patients, VEGF-TKIs have provided mode...
Sparad:
| Huvudupphov: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2021-06-01
|
| Serie: | Journal of Experimental & Clinical Cancer Research |
| Ämnen: | |
| Länkar: | https://doi.org/10.1186/s13046-021-01961-3 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|